Country selection
To offer the best possible experience tailored to your national regulatory requirements and the available product portfolio, please choose your country from the following list. This option will be saved throughout the browser session. Thank you!
User experience & privacy
We use cookies to offer you an optimal website experience. This includes cookies necessary for the operation of the website and for the control of our commercial corporate goals, as well as those only used for anonymous statistical purposes, comfort settings or to display personalized content. Please note that based on your settings, not all functions of the website may be available. To find out more, please refer to our Data Privacy Statement.

Eckert & Ziegler‘s GalliaPharm® distributed by Curium in France

Berlin, Germany & Paris, France

Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by extending their agreement for the distribution of Galliapharm® generators in France, Curium being the partner of choice given the national coverage of its PET network in France .

“Achieving greater market penetration for our core product GalliaPharm® is the focus of our sales strategy. With its established network in France, Curium is thus perfectly qualified to be our partner,” Dr. Harald Hasselmann, member of the Executive Board of Eckert & Ziegler AG and responsible for the Medical segment, explained. “In the coming years, Gallium-68 based diagnostics will become even more prevalent than today. Eckert & Ziegler is ideally equipped to serve these market needs. Since currently several clinical studies are conducted worldwide with so-called theranostics, we expect an increasing demand for both, the diagnostic radioisotope Gallium-68 and the therapeutic radioisotope Lutetium-177.”

“We are pleased to deploy Galliapharm® as part of our product portfolio and continue offering the highest and widest level of services to the nuclear physicians community”, Aurélie Gasse, General Manager Curium PET France stated.

GalliaPharm® is used in the diagnosis of neuroendocrine tumors and prostate cancer (Ga-68-PSMA) in countries all around the world. Gallium generators offer a low-cost alternative for the radiolabeling of biomolecules with Gallium-68 in PET, an imaging examination method used to detect the presence or absence of diseased tissue. PET Imaging is primarily used in the diagnosis of cancer, heart attacks or neurological diseases. Radioisotopes such as Fluorine-18 can be used alternatively but require investments of millions of Euros in large-scale equipment (cyclotrons). The Ge-68/Ga-68 generator on the other hand, is an easily transportable, small metal box and can be obtained much more cost-efficient, leading to cost reductions in nuclear medicine clinics and practices while increasing flexibility.

About Eckert & Ziegler Radiopharma GmbH

Eckert & Ziegler Radiopharma GmbH is a wholly owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG and part of Eckert & Ziegler’s Medical business segment. The company is specialized in the field of nuclear medicine and molecular imaging, providing radiopharmaceuticals and radiochemicals for diagnosis, treatment and research purposes. With the GalliaPharm® Ge-68/Ga-68 generator and Yttriga, sterile Yttrium-90 chloride solution, Radiopharma GmbH provides two core pharmaceutical products for diagnosis and therapy.

 About Curium PET France
Curium PET France results from the acquisition of Laboratoires Cyclopharma by the Curium Group. It develops and produces PET diagnostic tracers and since April 2020, manages CIS bio international’s (a Curium Group company) complete and autonomous PET products production and sales branch.

Curium PET France headquartered in Saint-Beauzire, operates twelve PET sites in France located in Nîmes, Paris, Sarcelles, Pessac, Rennes, Nancy, Toulouse, Tours, Glisy, Dijon, Janneyrias and Marseille.

Curium Group develops, manufactures and distributes world-class radiopharmaceutical products to help patients around the globe. Acting as the world leader in providing nuclear medicine solutions with over 100 years of combined industrial experience, Curium Group is the most vertically integrated radiopharmaceutical manufacturer in its industry.


Contact Eckert & Ziegler

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

13125 Berlin Germany

Phone: +49 30 941084 0

Fax: +49 30 941084 470



Contact Curium PET France

Curium PET France

3 Rue Marie Curie

Biopôle Clermont Limagne

Saint Beauzire 63360


Phone: +33 (0) 4 73 63 27 00



Get in touch

Contact us regarding your questions and we will get back to you as soon as possible.
By clicking send, you give your consent for processing your personal data in accordance with our Data Privacy Statement.
Permission required
In order to submit your request it is required to load a 3rd-party service (Google Re-Captcha spam protection system). You current privacy settings prevent this from happening automatically. By clicking the button below you explicitly allow to temporarily (on this page) load 3rd party services.